G-Pen™ for Hypoglycemia Rescue in T1D Patients

Summary

This is an open-label, exploratory pilot study in patients with T1D. The study will involve two daytime clinical research center visits 7-14 days apart. Subjects will receive a single injection of G-Pen™ (glucagon injection) at each visit.

Timeline

Start

2015-04

Primary completion

2015-05

Completion

2015-06

Drugs

Indications